Recently Viewed

Clear All
  • Home
  • Stories
  • News Announcement
  • Piramal Pharma: Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter Ended 30Th June 2026.
News Announcement

Piramal Pharma: Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter Ended 30Th June 2026.

20-Jul-2026 Follow Value Research Online on Google download pdfDownload PDF Piramal Pharma

Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for quarter ended 30th June 2026.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan